Elizabeth Holmes’ Partner Launches New Blood-Testing Startup
Billy Evans, the partner of Theranos founder Elizabeth Holmes, has reportedly embarked on a new medical venture focused on blood, saliva, and urine testing. The plan aims to offer “human health optimization,” according to pitch materials circulated to potential investors. Notably absent from the presentation is any direct mention of Evans’ connection to Holmes, now serving prison time for defrauding investors. Critics remain cautious, given Theranos’ infamous collapse after failing to deliver on revolutionary blood-testing promises. Supporters argue that new technology and stricter oversight could yield more reliable diagnostics.
|
Key Entities
- • Billy Evans: Entrepreneur and partner of Elizabeth Holmes, seeking to disrupt the medical testing space.
- • Elizabeth Holmes: Founder of Theranos, convicted of fraud for misleading investors about proprietary blood-testing technology.
- • Healthcare Investors: VC firms and private equity groups that evaluate high-risk, high-reward medical technologies.
Want to dive deeper?
We've prepared an in-depth analysis of this story with additional context and background.
Featuring Our Experts' Perspectives in an easy-to-read format.
Future Snapshot
See how this story could impact your life in the coming months
Exclusive Member Feature
Create a free account to access personalized Future Snapshots
Future Snapshots show you personalized visions of how insights from this story could positively impact your life in the next 6-12 months.
- Tailored to your life indicators
- Clear next steps and action items
- Save snapshots to your profile
Related Roadmaps
Explore step-by-step guides related to this story, designed to help you apply this knowledge in your life.
Loading roadmaps...
Please wait while we find relevant roadmaps for you.
Your Opinion
Would you trust a new blood-testing startup with ties to Elizabeth Holmes’ inner circle?
Your feedback helps us improve our content.
Comments (0)
Add your comment
No comments yet. Be the first to share your thoughts!
Related Stories
New Weight-Loss Drug Co-Pay Caps Aim to Boost Access as Feds Tackle High Prices
St. Louis, USA: Evernorth (Cigna’s health services arm) introduced a $200/month co-pay cap on popular GLP-1 weight-loss meds like Wegovy and...
HHS Moves Forward on “Most Favored Nation” Drug Pricing; Pharma Fights Back
Washington, D.C.: The Department of Health & Human Services, led by Robert F. Kennedy Jr., is implementing a “Most Favored Nation” model for...
MAHA Report: U.S. Facing Childhood Health “Emergency” from Chronic Illnesses
Washington, D.C.: A Trump administration-commissioned MAHA (Make Our Children Healthy Again) report warns of a “national emergency” in children’s...